Biological and Structural Characterization of Rotamers of C-C Chemokine Receptor Type 5 (CCR5) Inhibitor GSK214096.

Kazmierski, Wieslaw M; Danehower, Susan; Duan, Maosheng; Ferris, Robert G; Elitzin, Vassil; Minick, Douglas; Sharp, Matthew; Stewart, Eugene; Villeneuve, Manon

Kazmierski, Wieslaw M; Danehower, Susan; Duan, Maosheng; Ferris, Robert G; Elitzin, Vassil; Minick, Douglas; Sharp, Matthew; Stewart, Eugene; Villeneuve, Manon.

Afiliação

Kazmierski WM; Infectious Diseases TAU and Platform Technology and Science, GlaxoSmithKline , Five Moore Drive, Research Triangle Park, North Carolina 27709-3398, United States.
Danehower S; Infectious Diseases TAU and Platform Technology and Science, GlaxoSmithKline , Five Moore Drive, Research Triangle Park, North Carolina 27709-3398, United States.
Duan M; Infectious Diseases TAU and Platform Technology and Science, GlaxoSmithKline , Five Moore Drive, Research Triangle Park, North Carolina 27709-3398, United States.
Ferris RG; Infectious Diseases TAU and Platform Technology and Science, GlaxoSmithKline , Five Moore Drive, Research Triangle Park, North Carolina 27709-3398, United States.
Elitzin V; Infectious Diseases TAU and Platform Technology and Science, GlaxoSmithKline , Five Moore Drive, Research Triangle Park, North Carolina 27709-3398, United States.
Minick D; Infectious Diseases TAU and Platform Technology and Science, GlaxoSmithKline , Five Moore Drive, Research Triangle Park, North Carolina 27709-3398, United States.
Sharp M; Infectious Diseases TAU and Platform Technology and Science, GlaxoSmithKline , Five Moore Drive, Research Triangle Park, North Carolina 27709-3398, United States.
Stewart E; Infectious Diseases TAU and Platform Technology and Science, GlaxoSmithKline , Five Moore Drive, Research Triangle Park, North Carolina 27709-3398, United States.
Villeneuve M; Infectious Diseases TAU and Platform Technology and Science, GlaxoSmithKline , Five Moore Drive, Research Triangle Park, North Carolina 27709-3398, United States.